Vaccination with autoreactive T cell clones in multiple sclerosis: Overview of immunological and clinical data

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 500-511

  Stinissen, P ^a   Zhang, J ^a,b   Medaer, R ^a   Vandevyver, C ^a   Raus, J ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

autoimmunity; autoreactive lymphocytes; immunotherapy; myelin basic protein

Indexed keywords

MYELIN BASIC PROTEIN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; ATTENUATION; COMPLEMENT ACTIVATION; DEMYELINATION; IMMUNE RESPONSE; IMMUNOTHERAPY; MOLECULAR CLONING; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNITY; CLONE CELLS; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; T-LYMPHOCYTES; VACCINATION;

EID: 0029782340     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<500::AID-JNR21>3.0.CO;2-2     Document Type: Article

References (69)

1. Acha-Orbea H, Mitchell L, Timmerman L, et al. (1988): Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific intervention. Cell 54:263-273.
2. Acha-Orbea H, Steinman L, McDevitt HO (1989): T cell receptors in marine autoimmune diseases. Annu Rev Immunol 7:371-406.
3. Adorini L, Guery, JC, Trembleau, S (1992): Approaches toward peptide-based immunotherapy of autoimmune diseases. Springer Semin Immunopatho 4:187-199.
4. Allegretta M, Nicklas JA, Sriram S, Albertini RJ (1990): T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721.
5. Antel JP, Arnason BG, Medof ME (1979): Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol 5:338-342.
6. Ben-Nun A, Wekerle H, Cohen IR (1981a): Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292:60-61.
7. Ben-Nun A, Wekerle H, Cohen IR (1981b): The rapid isolation of clonable antigen specific T lymphocyte lines capable of mediating autoimmume encephalomyelitis. Eur J Immunol 11:195-199.
8. Ben-Nun A, Liblau RS, Cohen L, et al. (1991): Restricted T cell receptor V beta gene usage by MBP-specific T cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc Natl Acad Sci USA 88:2466-2470.
9. Cannella B, Raine CS (1995): The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424-435.
10. Chou YK, Vainiene M, Whitham R, et al. (1989): Response of human T lymphocyte lines to MBP: association of dominant epitopes with HLA class II restriction molecules. J Neurosc Res 23:207-216.
11. Chou YK, Bourdette DN, Offner H, et al. (1992): Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 38:105-113.
12. Chou YK, Morrison WJ, Weinberg AD, et al. (1994): Immunity to T cell receptor peptides in multiple sclerosis. II. T cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152:2520-2529.
13. Cohen IR (1992): The cognitive paradigm and the immunological homunculus. Immunol Today 13:490-494.
14. Cohen IR (1995): The life and times of T cell vaccination. In Zhang J, Raus J (eds): "T Cell Vaccination and Autoimmune Disease." Austin: Landes.
15. Ebers GC (1994): Treatment of multiple sclerosis. Lancet 343:275-279.
16. ffrench-Constant C (1994): Pathogenesis of multiple sclerosis. Lancet 343:271-275.
17. Hatter DA, Weiner HL (1987): In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis. Ann Neurol 22:89-93.
18. Hafler DA, Weiner HL (1989): MS: A CNS and systemic autoimmune disease. Immunol Today 10:104-107.
19. Hafler DA, Saadeh MG, Kuchroo VK, Milford E, Steinman L (1996): TCR usage in human and experimental demyelinating disease. Immunol Today 17:152-159.
20. Hofman FM, Hinton DR, Johnson K, et al. (1989): Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
21. Hohlfeld R, Meinl E, Weber F, et al. (1995): The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 45:S33-S38.
22. Holoshitz J, Matitiau A, Vohen IR (1985): Role of the thymus in induction and transfer of vaccination against adjuvant arthritis with a T lymphocyte line in rats. J Clin Invest 75:472-477.
23. Howell MD, Winters ST, Olee T, et al. (1989): Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-670.
24. IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995): Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45:1277-1285.
25. Jaraquemada D, Martin R, Rosen Bronson S, Flerlage M, McFarland HF, Long EO (1990): HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to MBP in DR2Dw2 individuals. J Immunol 145:2880-2885.
26. Johnson KP, Brooks BR, Cohen JA, et al. (1995): Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial. Neural 45:1268-1276.
27. Kerlero de Rosbo N, Milo R, Lees MB, et al. (1993): Reactivity to myelin antigens in Multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 92:2602-2608.
28. Kotzin BL, Karuturi S, Chou YK, et al. (1991): Preferential T cell receptor beta chain variable gene use in MBP reactive T cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88:9161-9165.
29. Kuchroo V, Sobel R, Laning J, et al. (1992): Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta gene usage. J Immunol 148:3776-3782.
30. Lehman PV, Forsthuber T, Miller A, Sercarz EE (1992): Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157.
31. Lehman PV, Sercarz EE, Forsthuber T, Dayan C, Gammon G (1993): Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 14:203-208.
32. Liblau R, Tournier-Lasserve E, Maciazek J, et al. (1991): T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjets. Eur J Immunol 21:1391-1395.
33. Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR (1988): Antiidiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181-183.
34. Lohse AW, Mor F, Karin N, Cohen IR (1989): Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244:820-822
35. Markovic-Plese S, Fukaura H, Zhang J, et al. (1995): T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 155:982-992.
36. Martin R, Jaraquemada D, Flerlage M, et al. (1990): Fine specificity and HLA restriction of myelin basic protein reactive cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145:540-548.
37. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol 148:1359-1366.
38. Martin R, McFarland HF (1995): Immunological aspect of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sc 32:121-182.
39. Medaer R, Stinissen P, Truyen L, Raus J, Zhang J (1995): Depletion of myelin-basic protein autoreactive T cells by T cell vaccination: Pilot trial in multiple sclerosis. Lancet 346:807-808.
40. Meinl E, Weber F, Drexler K, et al. (1993): Myelin basic protein specific T lymphocyte repertoire in multiple sclerosis: Complexity of the response and dominance of nested epitopes due to the recruitment of multiple T cell clones. J Clin Invest 92:2633-2644.
41. Naparstek Y, Holoshitz J, Eisenstein S, Reshef T, Rappaport S, Chemke J, Ben-Nun A, Cohen IR (1982): Effector T lymphocyte line cells migrate to the thymus and persist there. Nature 300:262-263
42. Oksenberg JM, Panzara A, Begovich AB, et al. (1993): Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in the brain lesions of multiple sclerosis. Nature 362:68-73.
43. Olerup O, Hillert J (1991): HLA class II associated genetic suscpetibility in multiple sclerosis: A critical evaluation. Tissue Antigens 38:1-15.
44. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990): T cell recognition of an immunodominant MBP epitope in multiple sclerosis. Nature 346:183-187.
45. Paty DW, Li DKB, the UBC MS/MRI Study Group (1993): Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662-667.
46. Pette M, Fujita K, Wilkinson D, et al. (1990): Myelin autoreactivity in multiple sclerosis: Recognition of MBP in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 87:7968-7972.
47. Prineas JW, Wright RG (1978): Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38:409-421.
48. Raine CS (1994): The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 36:S61-S72.
49. Salvetti M, Ristori G, D'amato M, et al. (1993): Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 23:1232-1239.
50. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991): Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954.
51. Steinman L (1991): The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 49:357-379.
52. Stinissen P, Raus J, Zhang J (1996): Autoimmune pathogenesis of Multiple Sclerosis: Role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol, in press.
53. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H (1988): Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T interactions. Nature 332:437-453.
54. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1988): A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 141:1126-1130.
55. Vandenbark A, Gill T, Offner H (1985): A myelin basic protein specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J Immunol 135:223-228.
56. Vandenbark AA, Hashim GA, Offner H (1989): Immunization with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544.
57. Vandenbark AA, Hashim G, Offner H (1993): TCR peptide therapy in autoimmune diseases, Intern Rev Immunol 9:251-276.
58. Vandevyver C, Mertens N, van den Elsen P, Medaer R, Raus J, Zhang J (1995): Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: Restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25:958-968.
59. Weiner HL, Mackin GA, Matsui M, et al. (1993): Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321-1326.
60. Wucherpfennig KW, Weiner HL, Hafler DA (1991): T-cell recognition of myelin basic protein. Immunol Today 12:277.
61. Wucherpfennig K, Sette A, Southwood S, et al. (1994a): Structural requirements for binding of an immunodominant myelin basic protein reactive peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179:279-290.
62. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler DA (1994b): Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 152:5581-5592.
63. Zamvil S, Mitchell D, Moore A, Kitamura K, Steinman S, Rothbard JB (1986): T cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258-260.
64. Zamvil SS, Steinman L (1990): The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579.
65. Zhang J, Medaer R, Chin Y, Hashim GA, et al. (1992): Myelin basic protein specific T lymphocytes: Precursor frequency, fine specificity and cytotoxicity. Ann Neurol 32:330-338.
66. Zhang J, Medaer R, Stinissen P, Hafler DA, Raus J (1993): MHC restricted clonotypic depletion of human myelin basic protein-reactive T cells by T cell vaccination, Science 261:1451-1454.
67. Zhang J, Markovic S, Lacet B, Raus J, Weiner, HL, Hafler DA (1994): Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973-984.
68. Zhang J, Vandevyver C, Stinissen P, et al. (1995a): Activation and clonal expansion of human myelin basic protein reactive T cells by bacterial superantigens. J Autoimmun 8:615-632.
69. Zhang J, Vandevyver C, Stinissen P, Raus J (1995b). In vivo clonotypic regulation of human myelin basic protein reactive T cells by T cell vaccination. J Immunol 155:5868-5877.